Non Surgical Rejuvenation - Chemical Peel / Fillers / Botox Flashcards
A plastic surgeon is asked by a local charity to donate his services to an annual fundraiser. Which of the following medical services is currently permitted by the code of ethics of the American Society of Plastic Surgeons (ASPS)?
A) Augmentation mammaplasty
B) Liposuction
C) Injection of botulinum toxin type A
D) Rhytidectomy
E) No services are permitted
The correct response is Option C.
Injection of botulinum toxin type A does not require an incision; therefore, it is not a medical procedure as defined by the American Society of Plastic Surgeons (ASPS). The ASPS defines a “procedure” (Section 2, Article I [K] of the code of ethics) as a medical service that requires an incision. Examples of medical services that require an incision include, but are not limited to, rhytidectomy, augmentation mammaplasty, blepharoplasty, and suction lipectomy. Examples of medical services that do not require an incision include, but are not limited to, injections (botulinum toxin type A, hyaluronic acid), microdermabrasion, and other skin surface treatments. The other options listed all require an incision and are therefore prohibited as donations.
Use of which of the following agents is CONTRAINDICATED prior to dermabrasion?
(A) Alpha-hydroxy acid
(B) Glycolic acid
(C) Hydroquinone 4%
(D) Isotretinoin
(E) Tretinoin
The correct response is Option D.
Isotretinoin (Accutane, also referred to as 13-cis retinoic acid) is contraindicated in a patient who is to undergo dermabrasion. Isotretinoin is an oral retinoid that is used to treat acne by suppressing keratinization and the function of sebaceous glands, thereby diminishing the oiliness of the skin. In patients undergoing isotretinoin therapy, dermabrasion or laser resurfacing should be deferred for at least one year following discontinuation of the drug, because delayed healing and hypertrophic scarring may occur.
Alpha-hydroxy and glycolic acids are mild agents typically found in many over-the-counter skin creams. These agents are not contraindicated in patients undergoing dermabrasion.
Hydroquinones are typically administered preoperatively and postoperatively to prevent hyperpigmentation.
Tretinoin is used for skin preparation in patients scheduled to undergo dermabrasion or laser therapy.
A 40-year-old woman comes to the office because of fine rhytides and skin discoloration caused by photoaging. Topical application of 0.025% tretinoin is planned. Which of the following best describes the mechanism of action of topical retinoid therapy?
A) Decreased activation of skin appendages resulting in thinning of the stratum corneum
B) Decreased corneocyte cohesion resulting in increased desquamation
C) Increased free radical scavenging activity and synthesis of Types I and III collagen
D) Inhibition of AP-1 transcription factor binding to DNA resulting in diminished protease activity
E) Inhibition of tyrosinase resulting in diminished conversion of dopamine to melanin
The correct response is Option D.
Tretinoin (all-trans-retinoic acid; Retin-A) is one of the best long-term topical therapies available for chronically photoaged skin. The mechanism of action of retinoids is regulated through specific nuclear receptors. Ultraviolet (UV) radiation activates a series of phosphokinases that stimulate c-Fos and c-Jun proto-oncogenes and thereby activate AP-1 transcription factor. AP-1 causes activation of metalloproteases such as collagenase, gelatinase, and stromelysin, which then break down collagen. Tretinoin results in a 70% inhibition of AP-1 transcription factor binding to DNA and a significant reduction in protease activity.
Long-term use of tretinoin is associated with improved skin texture, decreased sallowness, a reduction in fine rhytides and actinic keratosis, fading of pigmented macules, and an overall improvement in skin appearance. Histologic effects of tretinoin include increased epidermal and granular layer thickness; elimination of dysplasia, atypia, and microscopic actinic keratoses; uniform dispersion of melanin granules; increased collagen and glycosaminoglycan deposition in the papillary dermis; and diminished dermal elastosis, angiogenesis, and compaction/thinning of the stratum corneum.
Tretinoin side effects include erythema, photosensitivity, and desquamation. Patients are initially started on a low dose with nightly application until tolerance is achieved. Because tretinoin is a photosensitizer, sunscreen use is absolutely imperative. Topical retinoids should be used for a minimum of 3 to 4 months, with the greatest improvement after 1 year of use. Patients who use alpha-hydroxy acids concomitantly with topical retinoids will see a synergistic effect, and this combination is tolerated well in most patients.
Isotretinoin (13-cis retinoic acid; Accutane) impairs sebaceous gland activity, impairs epithelialization, and thins the stratum corneum. Alpha-hydroxy acids cause desquamation as a result of diminished corneocyte cohesion just above the granular cell layer. Dermal effects of these acids include increased collagen and glycosaminoglycan production. UV radiation-stimulated oxygen free radicals are the primary mediators of UV skin damage. Vitamin C has been shown to be the primary water-soluble nonenzymatic antioxidant that helps protect skin cells from UV radiation. Other functions of Vitamin C include increased Types I and III collagen production, decreased pigment synthesis, improved epidermal barrier function, and regeneration of oxidized Vitamin E. Hydroquinone impairs the conversion of dopamine to melanin. The result is decreased formation of melanin and increased degradation of melanosomes.
A 50-year-old woman has ptosis of the upper eyelids after undergoing injection of botulinum toxin to the glabellar region. This finding is most likely due to paresis of which of the following periorbital muscles?
(A) Corrugator
(B) Levator
(C) Mullers
(D) Orbicularis
(E) Procerus
The correct response is Option B.
Use of botulinum toxin for management of hyperkinetic frown lines and furrows is an effective primary, adjunctive, or prophylactic therapy for patients desiring facial rejuvenation. Adverse effects can be minimized with a thorough understanding of the facial soft-tissue anatomy, proper patient selection, and administration of the lowest effective doses with minimal volume of delivery.
The treatment of glabellar frown lines typically involves injection of toxin into the medial eyebrows (corrugators). Other targeted facial hyperkinetic lines include lateral canthal rhytides (crow €™s feet) and horizontal forehead furrows. Diffusion of the toxin into the levator muscles upon injection of toxin into the corrugator muscles causes blepharoptosis. This adverse effect typically lasts only a few weeks because the dose of migrated toxin to the affected muscle is reduced significantly from the site of initial injection.
Injection into the procerus at the central glabella or into the frontalis muscle for horizontal forehead furrows would not likely lead to involvement of the levator muscle of the eyelid. Similarly, injection of the lateral portion of the orbicularis oculi at the outer canthal rhytides would not lead to the findings described in this patient. Müller €™s muscle lies deep to the levator muscle and is less likely to be injured than the levator during eyelid procedures.
In preparation for fat injection, which of the following is the most appropriate technique for processing the lipoaspirate to yield the highest volume of viable fat cells?
(A) Balanced centrifugation
(B) Exposure to air
(C) Filtration
(D) Gravity sedimentation
(E) Rinsing with isotonic saline
The correct response is Option A.
Balanced centrifugation is the appropriate technique for preparing lipoaspirate. The sediment of the harvested material separates reliably with brief centrifugation. Filtration, rinsing, or straining should not be performed because these methods lead to disruption of the fragile fat cells. Air exposure, even briefly, results in cytoplasmic lysis, and drying should be avoided. Gravity sedimentation is the optimal process but is lengthy. Duration of one to two hours ex vivo would increase the risk of drying and lipolysis.
In a 65-year-old woman with Fitzpatrick type II skin, which of the following agents is the most effective single treatment of moderate facial rhytides?
(A) Ascorbic acid
(B) Glycolic acid
(C) Lactic acid
(D) Retinoic acid
(E) Trichloroacetic acid
The correct response is Option E.
Tretinoin and alpha-hydroxy acids, which include glycolic acids, are dependable components of any skin rejuvenation program. These products are well studied, and the results are predictable. Some improvement in fine wrinkles has been observed, although clear histologic improvement in photoaging remains controversial, with the primary clinical observations showing improvement in skin texture and €œclarity. € Alpha-hydroxy acids, such as glycolic acid, are commercially available for in-office application as peeling agents on a regular schedule. Antioxidants such as ascorbic acid (vitamin C) have shown some clinical promise in the prevention of photoaging. Trichloroacetic acid (TCA) produces superficial exfoliation in concentrations of 15% to 35% and is appropriate for the treatment of more defined wrinkles.
Hyaluronic acid is currently being studied as a useful adjunct in the treatment of depressed scars and facial irregularities. It is used as a filler substance for augmentation of lips and to correct lines and wrinkles as well. Available in Europe, South America, and Canada, it is not yet approved for use in the U.S.
Although TCA peels are generally regarded as safer than phenol peels, informed consent must include the potential complications of all chemical peels. Depth and consistency of peel with TCA is variable and depends on pretreatment with tretinoin/hydroquinone, strength of solution (10% to 25% for light peels, 30% to 35% for intermediate peels, and 50% to 60% for deep peels), and duration of application (sparse and pinkish white changes for superficial peel, dense white frosting for intermediate to deep peels). Patients with a history of perioral herpes simplex should be pretreated for 24 hours before and five days after chemical peel to decrease potential for herpetic reactivation and superinfection. TCA peels should be administered only by a physician.
Which of the following anatomic structures most effectively neutralizes trichloroacetic acid (TCA) in patients undergoing TCA peels?
A ) Epidermis
B ) Dermis
C ) Subcutaneous tissue
D ) Kidney
E ) Liver
The correct response is Option B.
In patients undergoing chemical peeling, the TCA is neutralized within the superficial dermal plexus, particularly by the protein keratin. Chemical peeling by TCA is associated with absence of systemic toxicity and adverse effects on the cardiovascular system. Therefore, these patients do not require monitoring using electrocardiogram during the procedure.
Phenol peels are absorbed in the systemic circulation to some extent. As a result, blood phenol level should be monitored. Cardiac irregularities are associated with phenol peel. Therefore, it is recommended that cardiac monitoring be performed during the procedure. Phenol is eliminated and excreted by the kidneys.
Which of the following substances is NOT contained in Jessner’s solution?
(A) Ethanol
(B) Glycolic acid
(C) Lactic acid
(D) Resorcinol
(E) Salicylic acid
The correct response is Option B.
Jessner’s solution is incorporated into skin peeling agents to even the depth of the peel and improve exfoliation. This solution, which contains ethanol, lactic acid, resorcinol, and salicylic acid, is often used for treatment of hyperpigmentation. The mechanism of action of Jessner’s solution is believed to be destruction of intracellular connections between keratinocytes as well as removal of the epidermis. Its use results in increased epidermal turnover and a decreased quantity of melanin-counting keratinocytes.
Because the depth of penetration of Jessner’s solution is limited, the rate of complications is decreased. Mild erythema develops following the first application, which may worsen over time. Additionally, frosting of the skin may be seen with further application.
A 41-year-old woman has been undergoing a series of intense pulsed-light therapy to treat fine wrinkles and areas of sun-induced hyperpigmentation on the face. She is pleased with the lightening of the brown spots but would like to see more improvement in the fine lines and skin texture. The patient €™s work schedule prohibits time off for recovery. Which of the following treatments is most appropriate for this patient?
(A) 4% Hydroquinone
(B) 30% Glycolic acid
(C) 30% Trichloroacetic acid
(D) 33% Phenol peel
(E) Jessner’s solution
The correct response is Option B.
A 30% glycolic peel is the best choice for this patient, who does not want a lengthy recovery period. Depth of injury will be limited to the stratum corneum and perhaps mild epidermal peeling. The patient must realize that her result will be more subtle than with a deeper peel. A series of treatments at monthly intervals is advisable for maintenance therapy. Glycolic acid is an alpha-hydroxy acid that promotes superficial desquamation and may stimulate cell turnover and collagen production. Solutions of 50% or 70% may be used for deeper peels. Depth of injury is also time-dependent, and the acid must be neutralized or washed off with water.
A trichloroacetic acid peel of 30% is stronger than a comparable strength of glycolic acid. This peel causes a medium-depth injury, extending to the papillary dermis, resulting in a period of erythema and epidermal healing that will be unacceptable to this patient. Trichloroacetic acid treatments are effective for skin tightening and mild hyperpigmentation. Strengths of this treatment typically range from 15% to 35%.
Phenol peels are also medium- to deeper-level peels that require a longer recovery time for healing. Hydroquinone is a melanin inhibitor that is used primarily for the management of hyperpigmentation. Jessner €™s solution (14% lactic acid, 14% resorcinol, and 14% salicylic acid) is often used in combination with trichloroacetic acid to create a medium-depth peel. Concerning adverse effects, studies have shown that skin treated with Jessner €™s solution showed a significantly increased degree of exfoliation when compared with glycolic acid.
Which of the following best describes the mechanism by which tretinoin inhibits collagen degradation in photoaged skin?
A. Upregulation of matrix metalloproteinases (MMPs)
B. Activation of c-Fos and c-Jun proto-oncogenes
C. Inhibition of activator protein-1 (AP-1) transcription factor
D. Stimulation of ultraviolet-induced phosphokinases
E. Enhancement of collagenase activity
Correct Answer C. Inhibition of activator protein-1 (AP-1) transcription factor
Tretinoin, a retinoid, exerts its effects by modulating gene expression through nuclear receptors. Ultraviolet (UV) radiation activates phosphokinases that stimulate c-Fos and c-Jun proto-oncogenes, leading to the activation of activator protein-1 (AP-1) transcription factor. AP-1 increases the expression of matrix metalloproteinases (MMPs) such as collagenase, gelatinase, and stromelysin, which degrade collagen and contribute to photoaging. Tretinoin inhibits AP-1 binding to DNA by approximately 70%, resulting in a significant decrease in MMP activity and subsequent collagen degradation.
Which of the following is the only cosmetic indication for which onabotulinumtoxinA (Botox Cosmetic) and abobotulinumtoxinA (Dysport) have been approved by the US Food and Drug Administration?
A) Cervical dystonia
B) Forehead lines
C) Glabellar lines
D) Vertical lip creases
The correct response is Option C.
The only FDA-approved cosmetic indication for the use of onabotulinumtoxinA and abobotulinumtoxinA is to temporarily improve the appearance of moderate to severe glabellar lines. Although these products are widely used to treat other cosmetic concerns, these are all considered off-label uses. To this point, there have been no definitive adverse event reports of distant spread of botulinum toxin products when used at appropriate doses for dermatologic indications. There have been reports of adverse events in doses used for dystonia, especially in children. RimabotulinumtoxinB is only approved for treating cervical dystonia. On November 22, 2011, the FDA released a report renaming botulinum toxin type A and botulinum toxin type B to ensure their safe use (see table). Some of the reasons were to emphasize the differences in dosing and indications, and that these products are not interchangeable. The FDA recently approved application of Botox Cosmetic for smile lines related to activity of the lateral orbicularis oculi.

Which of the following is the most appropriate method for decreasing the depth of a phenol chemical peel?
(A) Applying antibiotic ointment
(B) Taping the skin
(C) Using croton oil
(D) Using liquid soap
The correct response is Option D.
The depth of a phenol peel is decreased by using liquid soap, which increases the surface tension and thus decreases the penetration and absorption of the phenol.
Applying antibiotic ointment and taping the skin increase the depth of a phenol peel by providing a vapor barrier.
Phenol peels are typically based on croton oil, a skin irritant that increases the speed and depth of epidermal destruction. Phenol peels were previously performed according to the Baker formula, which involved placement of the phenol in a solution of distilled water, croton oil, and liquid soap. This formula is no longer used because the solution did not effectively dilute the toxicity of the phenol.
Chemical peel neutralization using 1% sodium bicarbonate would be recommended with which of the following peeling agents?
A) Glycolic acid
B) Jessner solution
C) Phenol-croton oil
D) Salicylic acid
E) Trichloroacetic acid (TCA)
The correct response is Option A.
The requirement for neutralization is specific to each peel and must be thoroughly understood before application. For instance, the trichloroacetic acid peel approach is a dynamic process that depends largely on clinical judgment and experience to assess the extent of frosting relative to peel depth in an effort to optimize results and minimize complications. Furthermore, peel neutralization is typically carried out with a basic solution such as 1% sodium bicarbonate, and is generally required only for specific acids, such as glycolic acid, whereas phenol-croton oil peels and Jessner solution cannot be neutralized. Salicylic acid does not need to be neutralized. TCA penetrates deep to the dermal-epidermal junction and is counteracted by dilution with saline. TCA cannot be neutralized at the end of treatment because it has penetrated too deeply.
A 36-year-old woman undergoes treatment of forehead wrinkles. Preoperative examination shows transverse rhytides when raising the eyebrows. Her eyebrows are 1 cm above the supraorbital rim. The central forehead is treated with 24 units of botulinum toxin type A. Two weeks later, the patient is unsatisfied with the appearance of her eyebrows. On examination, the medial eyebrow is located 1 cm above the supraorbital rim. Lateral eyebrows are raised significantly, creating an abnormal arch. Injection of additional botulinum toxin type A into which of the following muscles is the most appropriate treatment at this time?
A) Corrugator supercilia
B) Lateral frontalis
C) Levator palpebrae
D) Orbicularis oculi
E) Procerus
The correct response is Option B.
This patient has a “Spock’s eyebrow” deformity which occurs when the eyebrow has an excessive arch—the lateral brow is significantly higher compared the medial brow. This can happen when the medial frontalis is overtreated, resulting in a paradoxical effect on the lateral brow and an unnatural elevation of the lateral brow. Treatment of the deformity is with botulinum toxin type A injection into the lateral frontalis muscle (2 cm above the brow) which will allow the lateral brow to descend.
Facial rhytids are classified as static or dynamic. Botulinum toxin type A injections are useful for treating dynamic rhytids, which occur during muscle contraction. The effects of botulinum toxin type A are usually seen within 3 to 10 days and lasts for 3 to 6 months.
The frontalis muscles are brow elevators and are the only elevators in the upper face.
The glabella is a commonly treated area and includes the corrugator supercilia and procerus muscles. Contraction of procerus results in horizontal rhytids and contraction of corrugators result in vertical rhytids. Both are brow depressors.
The orbicularis oculi muscle is targeted for the treatment of “crow’s feet lines” or lateral canthal lines along the lateral orbital rim. The orbital portion of the orbicularis oculi depresses the eyebrows.
The levator palpebrae is a muscle in the upper eyelid and functions to elevate and retract the upper eyelid. Eyelid ptosis can occur with botulinum toxin type A treatment of the glabella if there is diffusion of botulinum toxin type A that effects the levator palpebrae.
Which of the following disorders is most likely to be successfully treated with botulinum toxin type A?
A) Bruxism
B) Cervical paroxysmal dyskinesia
C) Hemifacial dyskinesia
D) Tardive dyskinesia
E) Vertical maxillary excess
The correct response is Option C.
Botulinum toxin type A has good evidence demonstrating efficacy for the treatment of blepharospasms, hemifacial dyskinesia, cervical dystonia, post-stroke upper limb spasticity (not from paroxysmal dyskinesia—see below).
Bruxism is clenching/grinding of teeth and jaw and can occur either awake or asleep. Treatment includes splint therapy and pharmacotherapy. There have been published reports using botulinum toxin type A. However, while the amplitude of muscle contraction was decreased, it did not decrease the rhythm or number of bruxism episodes. At this time, there is no evidence that it is an effective treatment.
Tardive dyskinesia develops as a result of adverse effect of anti-psychotic medication. Botulinum toxin type A, which consists of VMAT2 (vesicular monoamine transporter 2) inhibitor such as deutetrabenazine or valbenazine, is not indicated in its treatment.
Paroxysmal dyskinesia is considered an immune-related movement disorder. It mainly affects the limbs but can also affect cervical muscles. Treatment includes systemic antibiotics, corticosteroids, and immune therapy such as rituximab. Botulinum toxin type A is not indicated.
Vertical maxillary excess is not treated with botulinum toxin type A.
A 35-year-old woman comes to the office for treatment of glabellar rhytides with botulinum toxin type A. A total of 20 units is used for the treatment, with 10 units injected into the region of each corrugator muscle. Ten days later, the patient returns to the office because of ptosis of the left upper eyelid. To help decrease the eyelid ptosis, an alpha-adrenergic agonist eye drop can be used to stimulate which of the following muscles?
A) Dilator pupillae
B) Frontalis
C) Levator palpebrae superioris
D) Müller
E) Orbicularis oculi
The correct response is Option D.
Eyelid ptosis is the result of an inadvertent effect of the botulinum toxin upon the levator palpebrae superioris muscle. This can occur during treatment of the glabellar region if the injection is performed within/below the orbital rim.
The ptosis that results from the weakening of the levator palpebrae superioris can be countered by the use of alpha-adrenergic eyedrops such as apraclonidine (Iopidine) or phenylephrine. These eyedrops will stimulate the Müller muscle, which is an accessory eyelid elevator that is located deep to the levator palpebrae superioris between the levator muscle and the conjunctiva of the upper eyelid. This can help improve the ptosis but not likely adequately resolve the problem until the effect of botulinum toxin type A has worn off.
The levator, frontalis, and orbicularis will not be affected by the use of the eyedrops. The iris will dilate because of the effects of the eyedrops. This however, will have no effect on the ptotic position of the eyelid.
The Fitzpatrick skin classification stratifies patients according to
(A) actinic skin damage and fine wrinkle formation
(B) the potential for pigmentary changes following chemical peeling
(C) their risk for cardiac toxicity associated with phenol peeling
(D) their risk for hypertrophic scarring following skin resurfacing
(E) thickness and laxity of facial skin
The correct response is Option B.
Fitzpatrick’s system is the most widely used method for classifying patients according to skin type in order to stratify their risk for the development of postinflammatory hyperpigmentation following chemical peeling and laser skin resurfacing. This method of classification is based on the patient’s skin pigmentation and subsequent response following exposure to ultraviolet light. A table representing this classification system is shown below.
Patients who have Fitzpatrick type I, type II, or type III skin have the lowest risk for development of hyperpigmentation following chemical peeling. In contrast, patients with type IV, type V, or type VI skin are at increased risk for pigmentary changes.

Treatment with poly-L-lactic acid (Sculptra) is most likely to correct the soft-tissue facial deformity associated with which of the following conditions?
A) Discoid lupus
B) Progressive hemifacial atrophy
C) Scleroderma
D) Secondary effects of HIV treatment
The correct response is Option D.
Poly-L-lactic acid, marketed as Sculptra, has been utilized for the treatment of HIV retroviral drug–related lipoatrophy since 1999. The images shown illustrate such a patient.
Since its initial use, the indications for utilization have broadened and include most etiologies of lipoatrophy with its second most common use for age-related changes. In patients with age-related facial changes, it has been useful for mid face rejuvenation and temporal hollowing. Similar to age-related changes is weight loss that, when mild, will also respond to poly-L-lactic acid but when severe, will require a rhytidectomy. Lipoatrophy secondary to discoid lupus has been reported to respond best to fat grafting. The least likely to respond to poly-L-lactic acid is progressive hemifacial atrophy due to the severity of the soft-tissue deformity and will usually require soft-tissue augmentation with a free flap in severe cases and fat grafting in mild cases.

Which of the following best describes the mechanism of action of botulinum toxin (Botox)?
(A) Inhibition of acetylcholine release at the neuromuscular junction
(B) Inhibition of messenger RNA-mediated production of acetylcholine
(C) Potentiation of the acetylcholine effect at the neuromuscular junction
(D) Prevention of acetylcholine binding at the neuromuscular junction
The correct response is Option A.
Botulinum toxin, also known as Botox, is an exotoxin derived from Clostridium botulinum bacteria. Its neuromuscular mechanism of action involves inhibition of the release of acetylcholine. Botulinum toxin is packaged (typically in units of 100) in a sterile, vacuum-dried form, which must be stored at -5%C (23%F). It can also be reconstituted by diluting it with nonpreserved saline at a rate of 2.5 U/.1 mL.
Botulinum toxin is currently approved by the Food and Drug Administration (FDA) for treatment of glabellar rhytides. However, it is increasingly being used as an “off label” treatment for dispersion of rhytides of the forehead and the periorbital, perioral, and platysmal regions.
A 45-year-old woman comes to the office because of deep rhytides caused by photoaging. Topical application of 35% trichloroacetic acid in combination with Jessner solution is planned. Which of the following best describes the clinical endpoint during application of this chemical peel?
A) Dark firm eschar
B) Grey hue
C) Hypopigmentation
D) Transparent frost with a pink background
E) Uniform deep white frost
The correct response is Option E.
The deep white frost indicates the endpoint for the depth of skin penetration with a deep rhytid chemical peel such as the combination Jessner/35% trichloroacetic acid solution. This indicates that the peel has penetrated into the upper reticular dermis. There is no pink hue because at this level there is vasospasm of the capillaries in the papillary dermis. This depth of penetration is for moderate and deep rhytides. This is a transient phenomenon. Capillary refill should return within 20 to 40 minutes.
A transparent frost with a pink background is the endpoint for a superficial peel, such as that done with a trichloroacetic solution (<30%) alone. This frost is due to the coagulation of proteins in the dermis and epidermis. The pink hue emanates from blood vessels that remain intact in the papillary dermis.
A grey hue indicates a deeper penetration with destruction to the dermis. This level of penetration could lead to abnormal healing, scarring, pigmentation, and texturing changes. Hypopigmentation and superficial epidermolysis are potential complications of a chemical peel and not clinical endpoints to determine depth of penetration.
A 51-year-old woman comes to the office because of unilateral swelling of the breast 1 year after subglandular silicone augmentation mammaplasty. The patient says she has not had any recent trauma, fever, or myalgia. Physical examination shows a periprosthetic fluid collection. No erythema or edema is noted. Which of the following is the most appropriate next step in management?
A) Needle aspiration, Gram staining, and culture
B) Oral administration of antibiotics and complete blood count
C) Reduction of activity and use of a support brassiere
D) Ultrasound-directed aspiration and cytology
The correct response is Option D.
The most important diagnosis that needs to be ruled out is anaplastic large T-cell lymphoma (ALCL). This is a rare (one per million) non-Hodgkin lymphoma that has been reported in women with and without breast implants. However, increasing case reports suggest an association with breast implants, although direct causation has not been established. In ALCL associated with breast implants, malignant cells infiltrate the periprosthetic capsule or the periprosthetic fluid collection. The criteria for diagnosis include malignant cytology, strong CD30 expression, and cytokeratin negativity. Therefore, ultrasound-directed aspiration and cytology is most appropriate.
Reduction of activity, wearing a support brassiere, and follow-up in 2 weeks would be appropriate for perioperative tissue edema but is not appropriate treatment for late seromas.
Needle aspiration with Gram staining and culture risks injury to the implant and would not give the cytology necessary to determine if ALCL were present.
Oral administration of antibiotics and complete blood count would not be warranted in this situation where infection is unlikely by history and physical examination.
Ultrasound-directed aspiration and drain placement alone would not give the cytology necessary to determine if ALCL were present.
Which of the following is the beneficial effect of pretreatment with tretinoin prior to facial chemical peel and laser resurfacing?
A) Decreased epidermal proliferation
B) Decreased fibroblast deposition of glycosaminoglycans
C) Increased collagen IV deposition
D) Increased epidermal melanin
E) Increased transit rate of keratinocytes through the epidermis
The correct response is Option E.
Tretinoin has long been established as a topical treatment that can improve photoaged skin by decreasing pigmentation and fine and coarse wrinkles. This is accomplished via activation of retinoic acid receptors and other not yet well-characterized molecular mechanisms. Epidermal hyperproliferation is induced, which results in a normalization of epidermal disarray and thickening of the epidermis. Additionally, fibroblast deposition of collagen and glycosaminoglycans is stimulated, increasing skin turgor and elasticity. The breakdown of collagen is reduced via the reduction of collagenase and promotion of collagenase inhibitors. Epidermal melanin is reduced because of the stable rate of melanin transfer from melanocytes to keratinocytes, whereas the transit rate of keratinocytes through the epidermis is increased.
A 26-year-old Korean woman reports that she is unhappy about the “square appearance of her jawline” and desires a softer facial shape without surgical intervention. Treatment with botulinum toxin type A is recommended. Which of the following is true as it relates to botulinum for masseteric hypertrophy?
A) Botulinum toxin type A injection is approved by the Food and Drug Administration for the treatment of masseter hypertrophy
B) Effects are invariably short-term
C) Headaches, while infrequently reported, usually are reported to occur several weeks after injection
D) Muscle bulk will not show significant volume reduction on CT scan
E) Temporary decrease in mastication force is the most common effect
The correct response is Option E.
A recent study by Shome et al demonstrated that after a series of botulinum toxin injections, masseter volume reduction lasted up to 4 years. Therefore, this treatment’s effects are not only short-term.
In a review by Peng et al, 30% of patients reported temporary decrease in mastication force after botulinum injection. Headaches, while infrequently reported, happen immediately after injection and resolve within 2 to 4 days after injection. When patients’ masseter volumes were measured before and after treatment, there was significant reduction in masseter volume (Chang et al).
Currently, botulinum toxin injection is an off-label use in treatment of masseter hypertrophy. Botulinum toxin is approved by the Food and Drug Administration for use in bladder dysfunction, migraine, glabellar lines, primary axillary hyperhidrosis, blepharospasm, strabismus, cervical dystonia, and upper limb spasticity.
A 55-year-old woman has had pain, swelling, and erythema of the left arm for the past 24 hours. She underwent mastectomy and axillary lymph node dissection on the left four years ago. On examination, she is afebrile. Laboratory studies show a leukocyte count that is within normal limits.
Which of the following is the most appropriate management?
(A) Lymphatic massage
(B) Application of a compression bandage and elevation of the extremity
(C) Topical application of an antibiotic
(D) Intravenous administration of an antibiotic
(E) Incision and drainage
The correct response is Option D.
In this patient who has had the spontaneous onset of cellulitis of the arm after undergoing axillary lymph node dissection, the most appropriate management is intravenous administration of an antistreptococcal antibiotic. Fever and leukocytosis are typically associated with cellulitis but are not required to make the diagnosis, as many of these patients will be afebrile and will not have an increased leukocyte count or absolute neutrophil count on serologic testing. Anti-streptolysin O titer may be positive.
Although lymphatic massage and compression and elevation of the extremity are useful in controlling the lymphedema associated with lymph node dissection, these measures will not treat cellulitis. Antibiotic therapy should not be based on the results of blood or tissue aspirate cultures because these often do not yield any growth. Topical application of an antibiotic will not effectively treat cellulitis. Incision and drainage of the affected site is not indicated.



